Inactive Instrument
Asarina Pharma AB Stock
Stocks
ASAP
SE0011641794
Biotechnology & Medical Research
OTC Markets Traded| 1 day | -31.03% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 71 | 2017-03-31 | |
Magnus Brisander
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Paul de Potocki
CHM | Chairman | 64 | 2017-12-31 |
Marianne Kock
BRD | Director/Board Member | 71 | 2017-12-31 |
| Director/Board Member | 52 | 2020-01-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -31.03% | -40.43% | - | - | 64.67K | |
| +0.03% | -5.67% | +50.74% | +76.76% | 70.61B | |
| +0.66% | -9.75% | +6.97% | +52.62% | 51.01B | |
| +0.31% | -0.14% | +8.84% | +32.99% | 48.1B | |
| +0.90% | -1.46% | +32.32% | +32.69% | 42.78B | |
| +2.21% | -6.61% | +302.05% | +701.45% | 40.67B | |
| -1.15% | -3.11% | +9.47% | +98.83% | 40.3B | |
| +0.45% | -1.20% | +9.11% | +43.54% | 30.59B | |
| -2.23% | -4.96% | +39.06% | +6.04% | 28.16B | |
| -1.16% | -1.84% | -6.09% | -11.99% | 24.36B | |
| Average | -3.10% | -2.81% | +50.27% | +114.77% | 41.84B | |
| Weighted average by Cap. | +0.15% | -2.97% | +52.16% | +119.00% |
Employees
6
